81_FR_22164 81 FR 22092 - Draft Environmental Assessment and Preliminary Finding of No Significant Impact Concerning Investigational Use of Oxitec OX513A Mosquitoes; Extension of Comment Period

81 FR 22092 - Draft Environmental Assessment and Preliminary Finding of No Significant Impact Concerning Investigational Use of Oxitec OX513A Mosquitoes; Extension of Comment Period

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

Federal Register Volume 81, Issue 72 (April 14, 2016)

Page Range22092-22093
FR Document2016-08678

The Food and Drug Administration (FDA) is extending the comment period for the notice that appeared in the Federal Register of March 14, 2016. In the notice, FDA requested comments on the Draft Environmental Assessment and Preliminary Finding of No Significant Impact Concerning Investigational Use of Oxitec OX513A Mosquitoes. The Agency is taking this action in response to requests for an extension to allow interested persons additional time to submit comments.

Federal Register, Volume 81 Issue 72 (Thursday, April 14, 2016)
[Federal Register Volume 81, Number 72 (Thursday, April 14, 2016)]
[Notices]
[Pages 22092-22093]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-08678]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2014-N-2235]


Draft Environmental Assessment and Preliminary Finding of No 
Significant Impact Concerning Investigational Use of Oxitec OX513A 
Mosquitoes; Extension of Comment Period

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; extension of comment period.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is extending the 
comment period for the notice that appeared in the Federal Register of 
March 14, 2016. In the notice, FDA requested comments on the Draft 
Environmental Assessment and Preliminary Finding of No Significant 
Impact Concerning Investigational Use of Oxitec OX513A Mosquitoes. The 
Agency is taking this action in response to requests for an extension 
to allow interested persons additional time to submit comments.

DATES: FDA is extending the comment period on the notice published 
March 14, 2016 (81 FR 13371). Submit either electronic or written 
comments by May 13, 2016.

ADDRESSES: You may submit comments as follows:

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: http://www.regulations.gov. 
Follow the instructions for submitting comments. Comments submitted 
electronically, including attachments, to http://www.regulations.gov 
will be posted to the docket unchanged. Because your comment will be 
made public, you are solely responsible for ensuring that your comment 
does not include any confidential information that you or a third party 
may not wish to be posted, such as medical information, your or anyone 
else's Social Security number, or confidential business information, 
such as a manufacturing process. Please note that if you include your 
name, contact information, or other information that identifies you in 
the body of your comments, that information will be posted on http://www.regulations.gov.
     If you want to submit a comment with confidential 
information that you do not wish to be made available to the public, 
submit the comment as a written/paper submission and in the manner 
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand delivery/Courier (for written/paper 
submissions): Division of Dockets Management (HFA-305), Food and Drug 
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Division of 
Dockets Management, FDA will post your comment, as well as any 
attachments, except for information submitted, marked and identified, 
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No. 
FDA-2014-N-2235 for ``Draft Environmental Assessment and Preliminary 
Finding of No Significant Impact Concerning Investigational Use of 
Oxitec OX513A Mosquitoes.'' Received comments will be placed in the 
docket and, except for those submitted as ``Confidential Submissions,'' 
publicly viewable at http://www.regulations.gov or at the Division of 
Dockets Management between 9 a.m. and 4 p.m., Monday through Friday.
     Confidential Submissions--To submit a comment with 
confidential information that you do not wish to be made publicly 
available, submit your comments only as a written/paper submission. You 
should submit two copies total. One copy will include the information 
you claim to be confidential with a heading or cover note that states 
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will 
review this copy, including the claimed confidential information, in 
its consideration of comments. The second copy, which will have the

[[Page 22093]]

claimed confidential information redacted/blacked out, will be 
available for public viewing and posted on http://www.regulations.gov. 
Submit both copies to the Division of Dockets Management. If you do not 
wish your name and contact information to be made publicly available, 
you can provide this information on the cover sheet and not in the body 
of your comments and you must identify this information as 
``confidential.'' Any information marked as ``confidential'' will not 
be disclosed except in accordance with 21 CFR 10.20 and other 
applicable disclosure law. For more information about FDA's posting of 
comments to public dockets, see 80 FR 56469, September 18, 2015, or 
access the information at: http://www.fda.gov/regulatoryinformation/dockets/default.htm.
    Docket: For access to the docket to read background documents or 
the electronic and written/paper comments received, go to http://www.regulations.gov and insert the docket number, found in brackets in 
the heading of this document, into the ``Search'' box and follow the 
prompts and/or go to the Division of Dockets Management, 5630 Fishers 
Lane, Rm. 1061, Rockville, MD 20852.
    Submit written requests for single copies of the draft 
Environmental Assessment (EA) and preliminary Finding of No Significant 
Impact (FONSI) to the Policy and Regulations Staff (HFV-6), Center for 
Veterinary Medicine, Food and Drug Administration, 7519 Standish Pl., 
Rockville, MD 20855. Send one self-addressed adhesive label to assist 
that office in processing your requests. Persons with access to the 
Internet may obtain the draft EA and preliminary FONSI at either http://www.fda.gov/animalveterinary/developmentapprovalprocess/environmentalassessments/ucm300656.htm or http://www.regulations.gov.

FOR FURTHER INFORMATION CONTACT: Brinda Dass, Center for Veterinary 
Medicine (HFV-2), Food and Drug Administration, 7500 Standish Pl., 
Rockville, MD 20855, 240-276-8247, email: [email protected].

SUPPLEMENTARY INFORMATION: In the Federal Register of March 16, 2016, 
FDA published a notice with a 30-day comment period to request comments 
on the Draft Environmental Assessment and Preliminary Finding of No 
Significant Impact Concerning Investigational Use of Oxitec OX513A 
Mosquitoes.
    The Agency has received requests for a 90-day extension of the 
comment period for the notice. Each request conveyed concern that the 
current 30-day comment period does not allow sufficient time to develop 
a meaningful or thoughtful response to the notice.
    FDA has considered the requests and is extending the comment period 
for the notice for 30 days, until May 13, 2016. The Agency believes 
that a 30-day extension allows adequate time for interested persons to 
submit comments without significantly delaying the Agency's decision on 
whether to finalize these documents or prepare an Environmental Impact 
Statement.

    Dated: April 7, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016-08678 Filed 4-13-16; 8:45 am]
 BILLING CODE 4164-01-P



                                                  22092                         Federal Register / Vol. 81, No. 72 / Thursday, April 14, 2016 / Notices

                                                  activities by Women of Color Network,                   resource sharing for the FVPSA state                  www.regulations.gov will be posted to
                                                  Inc. (WOCN).                                            administrators, graduates and                         the docket unchanged. Because your
                                                                                                          community-based organizations;                        comment will be made public, you are
                                                  SUMMARY:    The Administration for                      evaluation and documentation of how                   solely responsible for ensuring that your
                                                  Children and Families (ACF),                            the technical assistance and processes                comment does not include any
                                                  Administration on Children, Youth and                   improved the skills, access, engagement               confidential information that you or a
                                                  Families (ACYF), Family and Youth                       and/or participation of the graduates,                third party may not wish to be posted,
                                                  Services Bureau (FYSB), Division of                     state administrators and community-                   such as medical information, your or
                                                  Family Violence and Prevention                          based organizations.                                  anyone else’s Social Security number, or
                                                  Services (DFVPS) announces the award                                                                          confidential business information, such
                                                                                                            Statutory Authority: Section 310 of the
                                                  of $175,000 as a single-source grant to                                                                       as a manufacturing process. Please note
                                                                                                          Family Violence Prevention and Services
                                                  the Pennsylvania Coalition Against                      Act, as amended by Section 201 of the                 that if you include your name, contact
                                                  Domestic Violence (PCADV) in                            CAPTA Reauthorization Act of 2010, Pub. L.            information, or other information that
                                                  Harrisburg, PA, to support activities by                111–320.                                              identifies you in the body of your
                                                  Women of Color Network Inc. (WOCN).                                                                           comments, that information will be
                                                  The grantee, funded under the FVPSA                     Christopher Beach,
                                                                                                                                                                posted on http://www.regulations.gov.
                                                  program, is a technical assistance                      Senior Grants Policy Specialist, Office of              • If you want to submit a comment
                                                  provider that assists FVPSA service                     Administration.                                       with confidential information that you
                                                  providers to build the capacity of                      [FR Doc. 2016–08534 Filed 4–13–16; 8:45 am]           do not wish to be made available to the
                                                  domestic violence programs.                             BILLING CODE 4184–32–P                                public, submit the comment as a
                                                  DATES: The period of support for the                                                                          written/paper submission and in the
                                                  single-source program expansion                                                                               manner detailed (see ‘‘Written/Paper
                                                                                                          DEPARTMENT OF HEALTH AND                              Submissions’’ and ‘‘Instructions’’).
                                                  supplement is September 30, 2015
                                                                                                          HUMAN SERVICES
                                                  through September 29, 2016.                                                                                   Written/Paper Submissions
                                                  FOR FURTHER INFORMATION CONTACT:                        Food and Drug Administration                             Submit written/paper submissions as
                                                  Shena Williams, Senior Program                                                                                follows:
                                                  Specialist, Family Violence Prevention                  [Docket No. FDA–2014–N–2235]
                                                                                                                                                                   • Mail/Hand delivery/Courier (for
                                                  and Services Program, 330 C Street SW.,                 Draft Environmental Assessment and                    written/paper submissions): Division of
                                                  Washington, DC 20201. Telephone:                        Preliminary Finding of No Significant                 Dockets Management (HFA–305), Food
                                                  202–205–5932; Email: Shena.Williams@                    Impact Concerning Investigational Use                 and Drug Administration, 5630 Fishers
                                                  acf.hhs.gov.                                            of Oxitec OX513A Mosquitoes;                          Lane, Rm. 1061, Rockville, MD 20852.
                                                  SUPPLEMENTARY INFORMATION: Grant                        Extension of Comment Period                              • For written/paper comments
                                                  funds will support WOCN, through the                                                                          submitted to the Division of Dockets
                                                  PCADV, to provide training and                          AGENCY:    Food and Drug Administration,              Management, FDA will post your
                                                  technical assistance to individuals and                 HHS.                                                  comment, as well as any attachments,
                                                  organizations dedicated to enhancing                    ACTION:   Notice; extension of comment                except for information submitted,
                                                  services to those in historically                       period.                                               marked and identified, as confidential,
                                                  marginalized communities in domestic                                                                          if submitted as detailed in
                                                  violence programs across the country.                   SUMMARY:   The Food and Drug                          ‘‘Instructions.’’
                                                    The WOCN will provide technical                       Administration (FDA) is extending the                    Instructions: All submissions received
                                                  assistance and training to FVPSA state                  comment period for the notice that                    must include the Docket No. FDA–
                                                  administrators to strengthen                            appeared in the Federal Register of                   2014–N–2235 for ‘‘Draft Environmental
                                                  collaborative efforts of state                          March 14, 2016. In the notice, FDA                    Assessment and Preliminary Finding of
                                                  administrators and community-based                      requested comments on the Draft                       No Significant Impact Concerning
                                                  organizations for the purposes of                       Environmental Assessment and                          Investigational Use of Oxitec OX513A
                                                  improving services to victims of                        Preliminary Finding of No Significant                 Mosquitoes.’’ Received comments will
                                                  domestic violence in diverse and                        Impact Concerning Investigational Use                 be placed in the docket and, except for
                                                  historically marginalized communities.                  of Oxitec OX513A Mosquitoes. The                      those submitted as ‘‘Confidential
                                                    This project may include such                         Agency is taking this action in response              Submissions,’’ publicly viewable at
                                                  activities as listening sessions to                     to requests for an extension to allow                 http://www.regulations.gov or at the
                                                  identify specific needs, challenges and                 interested persons additional time to                 Division of Dockets Management
                                                  barriers to funding, services and                       submit comments.                                      between 9 a.m. and 4 p.m., Monday
                                                  collaborative efforts; documentation of                 DATES: FDA is extending the comment                   through Friday.
                                                  technical assistance needs; and                         period on the notice published March                     • Confidential Submissions—To
                                                  development of state-specific technical                 14, 2016 (81 FR 13371). Submit either                 submit a comment with confidential
                                                  assistance plans and written                            electronic or written comments by May                 information that you do not wish to be
                                                  recommendations for fostering and                       13, 2016.                                             made publicly available, submit your
                                                  sustaining collaborative partnerships                   ADDRESSES: You may submit comments                    comments only as a written/paper
                                                  and capacity-building activities.                       as follows:                                           submission. You should submit two
                                                    In addition to the issue of capacity-                                                                       copies total. One copy will include the
                                                                                                          Electronic Submissions
mstockstill on DSK4VPTVN1PROD with NOTICES




                                                  building activities, the grantee will                                                                         information you claim to be confidential
                                                  provide support and training to address                   Submit electronic comments in the                   with a heading or cover note that states
                                                  the identified barriers including gaps in               following way:                                        ‘‘THIS DOCUMENT CONTAINS
                                                  leadership development. Training will                     • Federal eRulemaking Portal: http://               CONFIDENTIAL INFORMATION.’’ The
                                                  include such activities as targeted                     www.regulations.gov. Follow the                       Agency will review this copy, including
                                                  technical assistance for state                          instructions for submitting comments.                 the claimed confidential information, in
                                                  administrators, graduates and                           Comments submitted electronically,                    its consideration of comments. The
                                                  community-based organizations;                          including attachments, to http://                     second copy, which will have the


                                             VerDate Sep<11>2014   17:56 Apr 13, 2016   Jkt 238001   PO 00000   Frm 00045   Fmt 4703   Sfmt 4703   E:\FR\FM\14APN1.SGM   14APN1


                                                                                Federal Register / Vol. 81, No. 72 / Thursday, April 14, 2016 / Notices                                                 22093

                                                  claimed confidential information                        period for the notice. Each request                      Open: May 4, 2016.
                                                  redacted/blacked out, will be available                 conveyed concern that the current 30-                    Time: 8:30 a.m. to 4:00 p.m.
                                                  for public viewing and posted on                        day comment period does not allow                        Agenda: This portion of the meeting will
                                                                                                                                                                be open to the public for announcements and
                                                  http://www.regulations.gov. Submit                      sufficient time to develop a meaningful
                                                                                                                                                                reports of administrative, legislative, and
                                                  both copies to the Division of Dockets                  or thoughtful response to the notice.                 program developments in the drug abuse
                                                  Management. If you do not wish your                        FDA has considered the requests and                field.
                                                  name and contact information to be                      is extending the comment period for the                  Place: National Institutes of Health,
                                                  made publicly available, you can                        notice for 30 days, until May 13, 2016.               Neuroscience Center, 6001 Executive
                                                  provide this information on the cover                   The Agency believes that a 30-day                     Boulevard, Rockville, MD 20852.
                                                  sheet and not in the body of your                       extension allows adequate time for                       Contact Person: Susan R.B. Weiss, Ph.D.,
                                                                                                          interested persons to submit comments                 Director, Division of Extramural Research,
                                                  comments and you must identify this
                                                                                                          without significantly delaying the                    Office of the Director, National Institute on
                                                  information as ‘‘confidential.’’ Any                                                                          Drug Abuse, NIH, DHHS, 6001 Executive
                                                  information marked as ‘‘confidential’’                  Agency’s decision on whether to                       Boulevard, NSC, Room 5274, MSC 9591,
                                                  will not be disclosed except in                         finalize these documents or prepare an                Rockville, MD 20892, 301–443–6487,
                                                  accordance with 21 CFR 10.20 and other                  Environmental Impact Statement.                       sweiss@nida.nih.gov.
                                                  applicable disclosure law. For more                       Dated: April 7, 2016.                                  Any member of the public interested in
                                                  information about FDA’s posting of                      Leslie Kux,                                           presenting oral comments to the committee
                                                  comments to public dockets, see 80 FR                                                                         may notify the Contact Person listed on this
                                                                                                          Associate Commissioner for Policy.
                                                  56469, September 18, 2015, or access                                                                          notice at least 10 days in advance of the
                                                                                                          [FR Doc. 2016–08678 Filed 4–13–16; 8:45 am]           meeting. Interested individuals and
                                                  the information at: http://www.fda.gov/                 BILLING CODE 4164–01–P                                representatives of organizations may submit
                                                  regulatoryinformation/dockets/                                                                                a letter of intent, a brief description of the
                                                  default.htm.                                                                                                  organization represented, and a short
                                                     Docket: For access to the docket to                  DEPARTMENT OF HEALTH AND                              description of the oral presentation. Only one
                                                  read background documents or the                        HUMAN SERVICES                                        representative of an organization may be
                                                  electronic and written/paper comments                                                                         allowed to present oral comments and if
                                                  received, go to http://                                 National Institutes of Health                         accepted by the committee, presentations
                                                  www.regulations.gov and insert the                                                                            may be limited to five minutes. Both printed
                                                                                                          National Institute on Drug Abuse;                     and electronic copies are requested for the
                                                  docket number, found in brackets in the
                                                                                                          Notice of Meeting                                     record. In addition, any interested person
                                                  heading of this document, into the                                                                            may file written comments with the
                                                  ‘‘Search’’ box and follow the prompts                      Pursuant to section 10(d) of the                   committee by forwarding their statement to
                                                  and/or go to the Division of Dockets                    Federal Advisory Committee Act, as                    the Contact Person listed on this notice. The
                                                  Management, 5630 Fishers Lane, Rm.                      amended (5 U.S.C. App.), notice is                    statement should include the name, address,
                                                  1061, Rockville, MD 20852.                                                                                    telephone number and when applicable, the
                                                                                                          hereby given of a meeting of the
                                                     Submit written requests for single                                                                         business or professional affiliation of the
                                                                                                          National Advisory Council on Drug                     interested person.
                                                  copies of the draft Environmental                       Abuse.
                                                  Assessment (EA) and preliminary                                                                                  Information is also available on the
                                                                                                             The meeting will be open to the                    Institute’s/Center’s home page:
                                                  Finding of No Significant Impact                        public as indicated below, with                       www.drugabuse.gov/NACDA/
                                                  (FONSI) to the Policy and Regulations                   attendance limited to space available.                NACDAHome.html, where an agenda and
                                                  Staff (HFV–6), Center for Veterinary                    Individuals who plan to attend and                    any additional information for the meeting
                                                  Medicine, Food and Drug                                 need special assistance, such as sign                 will be posted when available.
                                                  Administration, 7519 Standish Pl.,                      language interpretation or other                      (Catalogue of Federal Domestic Assistance
                                                  Rockville, MD 20855. Send one self-                     reasonable accommodations, should                     Program Nos.: 93.279, Drug Abuse and
                                                  addressed adhesive label to assist that                 notify the Contact Person listed below                Addiction Research Programs, National
                                                  office in processing your requests.                     in advance of the meeting.                            Institutes of Health, HHS)
                                                  Persons with access to the Internet may                    The meeting will be closed to the                    Dated: April 8, 2016.
                                                  obtain the draft EA and preliminary                     public in accordance with the                         Natasha M. Copeland,
                                                  FONSI at either http://www.fda.gov/                     provisions set forth in sections                      Program Analyst, Office of Federal Advisory
                                                  animalveterinary/developmentapproval                    552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,            Committee Policy.
                                                  process/environmentalassessments/                       as amended. The grant applications                    [FR Doc. 2016–08523 Filed 4–13–16; 8:45 am]
                                                  ucm300656.htm or http://                                and/or contract proposals and the                     BILLING CODE 4140–01–P
                                                  www.regulations.gov.                                    discussions could disclose confidential
                                                  FOR FURTHER INFORMATION CONTACT:                        trade secrets or commercial property
                                                  Brinda Dass, Center for Veterinary                      such as patentable material, and                      DEPARTMENT OF HOMELAND
                                                  Medicine (HFV–2), Food and Drug                         personal information concerning                       SECURITY
                                                  Administration, 7500 Standish Pl.,                      individuals associated with the grant
                                                  Rockville, MD 20855, 240–276–8247,                      applications and/or contract proposals,               Transportation Security Administration
                                                  email: abig@fda.hhs.gov.                                the disclosure of which would
                                                  SUPPLEMENTARY INFORMATION: In the                       constitute a clearly unwarranted                      Intent To Request Renewal From OMB
                                                  Federal Register of March 16, 2016,                     invasion of personal privacy.                         of One Current Public Collection of
                                                  FDA published a notice with a 30-day                      Name of Committee: National Advisory                Information: Baseline Assessment for
                                                                                                                                                                Security Enhancement (BASE)
mstockstill on DSK4VPTVN1PROD with NOTICES




                                                  comment period to request comments                      Council on Drug Abuse.
                                                  on the Draft Environmental Assessment                     Date: May 3–4, 2016.                                Program
                                                  and Preliminary Finding of No                             Closed: May 3, 2016.
                                                                                                            Time: 2:00 p.m. to 4:00 p.m.                        AGENCY:  Transportation Security
                                                  Significant Impact Concerning                             Agenda: To review and evaluate grant                Administration, DHS.
                                                  Investigational Use of Oxitec OX513A                    applications and/or proposals.                        ACTION: 60-Day notice.
                                                  Mosquitoes.                                               Place: National Institutes of Health,
                                                     The Agency has received requests for                 Neuroscience Center, 6001 Executive                   SUMMARY: The Transportation Security
                                                  a 90-day extension of the comment                       Boulevard, Rockville, MD 20852.                       Administration (TSA) invites public


                                             VerDate Sep<11>2014   17:56 Apr 13, 2016   Jkt 238001   PO 00000   Frm 00046   Fmt 4703   Sfmt 4703   E:\FR\FM\14APN1.SGM   14APN1



Document Created: 2018-02-07 13:48:24
Document Modified: 2018-02-07 13:48:24
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice; extension of comment period.
DatesFDA is extending the comment period on the notice published March 14, 2016 (81 FR 13371). Submit either electronic or written comments by May 13, 2016.
ContactBrinda Dass, Center for Veterinary Medicine (HFV-2), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 240-276-8247, email: [email protected]
FR Citation81 FR 22092 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR